Other innovative therapies in Duchenne muscular dystrophy.

Over the past three decades, new therapeutic strategies have been developed to treat Duchenne muscular dystrophy (DMD). These strategies aim to correct the primary genetic defect, compensate for secondary pathological changes resulting from muscular dystrophy, or stimulate skeletal muscle growth and regeneration to overcome muscle wasting. This article discusses three concepts currently being tested on patients with DMD: strategies for restoring dystrophin, next-generation pharmacological agents, and cell therapy.